Astronics Corporation reports results for the quarter ended June 30 - Earnings Summary
Astronics Corporation reports results for the quarter ended June 30 - Earnings Summary
Astronics Corporation ATRO.OQ reported quarterly adjusted earnings of 70 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 4 cents. The mean expectation of four analysts for the quarter was for earnings of 69 cents per share. Wall Street expected results to range from 66 cents to 74 cents per share.
Revenue rose 27% to $259.96 million from a year ago; analysts expected $245.23 million.
Astronics Corporation's reported EPS for the quarter was 75 cents.
The company reported quarterly net income of $35.06 million.
Astronics Corporation shares had fallen by 7.1% this quarter and gained 67.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 7.8% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the aerospace & defense peer group is also "buy"
Wall Street's median 12-month price target for Astronics Corporation is $100.00, about 24.5% above its last closing price of $75.46
This summary was machine generated from LSEG data August 11 at 10:20 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.69 | 0.70 | Beat |
Mar. 31 2026 | 0.56 | 0.59 | Beat |
Dec. 31 2025 | 0.60 | 0.75 | Beat |
Sep. 30 2025 | 0.42 | 0.49 | Beat |
Recent news on Astronics
See all newsAstronics Corporation reports results for the quarter ended September 30 - Earnings Summary
Astronics Q3 sales beat estimates on aerospace demand; maintains 2026 revenue guidance
Brief: Astronics Q3 Sales USD 271.679 Million Vs. IBES Estimate USD 268 Million
US RESEARCH ROUNDUP- Amgen, Lockheed Martin, Norfolk Southern
US RESEARCH ROUNDUP-3M, C4 Therapeutics, PepsiCo